Home/ Supplements/ Pregnenolone/ Cognitex With Pregnenolone & Brain Sheil...

Cognitex With Pregnenolone & Brain Sheild (Gastrodin)

product on market Softgel Capsule Life Extension Safety: 90/100
90/100

This product looks safe

  • Contains proprietary blend — exact ingredient amounts not disclosed
  • 30% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains phospholipids and pregnenolone, which are studied for supporting cognitive function and membrane integrity. While ingredients like phosphatidylserine have moderate evidence for brain health, overall clinical data for this specific combination is limited. The profile maintains a high safety score with no major contraindications noted.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Contains proprietary blend — exact ingredient amounts not disclosed

Label

Product Label

Label for Cognitex With Pregnenolone & Brain Sheild (Gastrodin)
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Softgel(s)
Serving Size
30
Servings
Other Combinations
Product Type
30%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

1.1× RDA — within safe limits 38 studies (A:1, B:7)
Market median: 100.0mg (108 products)
Brain Shield
50 mg
50 mg
Market median: 30.0mg (45 products)
Vinpocetine
20 mg
Leucoselect Grape extract
150 mg
BlueActiv Wild Blueberry extract
150 mg
Market median: 450.0mg (502 products) 28 studies (A:0, B:8)
Within RDA (0.1× RDA) 13 studies (A:0, B:3)
Proprietary NeuroProtection Complex Blend
125 mg

Other Ingredients

Safflower Oil Gelatin Glycerin Sunflower Lecithin purified Water Sorbitol Maltodextrin Carob color Silica modified Food Starch
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

DIRECTIONS: Take three (3) softgels in the morning with or without food, or as recommended by a healthcare practitioner.

Warnings & Precautions

WARNING: NOT FOR USE BY INDIVIDUALS UNDER THE AGE OF 18 YEARS. DO NOT USE IF PREGNANT OR NURSING. Consult a physician or licensed qualified health care professional before using this product if you have, or have a family history of breast cancer, prostate cancer, prostate enlargement, heart disease, low “good” cholesterol (HDL), or if you are using any other dietary supplement, prescription drug, or over-the-counter drug.

Do not exceed recommended serving. Exceeding recommended serving may cause serious adverse health effects. Possible side effects include acne, hair loss, hair growth on the face (in women), aggressiveness, irritability, and increased levels of estrogen. Discontinue use and call a physician or licensed qualified health care professional immediately if you experience rapid heartbeat, dizziness, blurred vision, or other similar symptoms. Do not take this product if you have a history of seizures.

If you are taking anti-coagulant or anti-platelet medications, or have a bleeding disorder, consult with your healthcare provider before taking this product.

KEEP OUT OF REACH OF CHILDREN.

Do not purchase if outer seal is broken or damaged.

Additional Information

Scan for product info

Read the entire label and follow the directions carefully prior to use.

Enhances Cognitive Function*

Sharp-PS Green

To report any adverse events call 1-800-332-1088.

Store tightly closed in a cool, dry place.

Q01897G

Metadata

Product Details

UPC / SKU7 37870 18979 4
DSLD Entry Date2016-06-24
Product TypeOther Combinations
FormSoftgel Capsule
DSLD ID60562
Data Updated2026-04-11
Research

Research Evidence

9
Research Sources
38
Avg Quality
5
Rct
2
Narrative Review
2
Other
B Effect of Pregnenolone vs Placebo on Self-reported Chronic Low Back Pain Among US Military Veterans: A Randomized Clinical Trial
Rct JAMA network open 2020 PubMed DOI
C Pregnenolone Reduces Stress-Induced Craving, Anxiety, and Autonomic Arousal in Individuals with Cocaine Use Disorder
Rct Biomolecules 2022 PubMed DOI
C Pregnenolone for cognition and mood in dual diagnosis patients
Rct Psychiatry research 2010 PubMed DOI
C Reduced urine pregnenolone concentration after clinical response in patients with depression: An open-label short-term prospective study
Rct Psychoneuroendocrinology 2023 PubMed DOI
C Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia
Rct Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2009 PubMed DOI
D Mitochondrial cytochrome P450 1B1 is involved in pregnenolone synthesis in human brain cells
Other The Journal of biological chemistry 2023 PubMed DOI
D Increased steroid hormone dehydroepiandrosterone and pregnenolone levels in post-mortem brain samples of alcoholics
Other Alcohol (Fayetteville, N.Y.) 2016 PubMed DOI
D Pregnenolone sulfate in the brain: a controversial neurosteroid
Narrative Review Neurochemistry international 2008 PubMed
D Individual differences in cognitive aging: implication of pregnenolone sulfate
Narrative Review Progress in neurobiology 2003 PubMed
View all evidence for Pregnenolone →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.